BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4674391)

  • 1. [Plasma TSH values in normal subjects and patients with various endocrine disorders].
    Hiroshige N; Kanao K; Inoue M; Sakoda M; Otsuki M
    Nihon Naibunpi Gakkai Zasshi; 1972 Nov; 48(8):569-77. PubMed ID: 4674391
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of a synthetic thyrotrophin releasing hormone (TRH) in normal and endocrinopathic subjects.
    Faglia G; Beck-Peccoz P; Ambrosi B; Ferrari C; Travaglini P
    Acta Endocrinol (Copenh); 1972 Oct; 71(2):209-25. PubMed ID: 4627179
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of the radioimmunoassay of serum thyrotrophin in man.
    Hershman JM; Pittman JA
    Ann Intern Med; 1971 Apr; 74(4):481-90. PubMed ID: 4994544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radioimmunoassay of thyrotropin (TSH) in human plasma].
    Freychet P; Rosselin G; Dolais J
    Presse Med (1893); 1969 Jan; 77(1):13-6. PubMed ID: 5785755
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyroptropin releasing factor (TRF) in patients with pituitary tumors.
    Faglia G; Beck Peccoz P; Ambrosi B; Ferrari C; Neri V
    J Clin Endocrinol Metab; 1971 Dec; 33(6):999-1002. PubMed ID: 5002719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radioimmunoassay of serum testosterone--results of the study of normal subjects and patients with endocrine disorders].
    Baba H
    Nihon Naibunpi Gakkai Zasshi; 1973 Jan; 49(1):60-79. PubMed ID: 4734772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of plasmatic TSH in pituitary neoplasms after stimulation with thyrotropin releasing hormone (TRH)].
    Silvestrini F; Liuzzi A; Chiodini PG; Cattabeni A; Botalla L
    Folia Endocrinol; 1973 Oct; 26(5):398-406. PubMed ID: 4203133
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperthyroidism and high serum levels of TSH associated with pituitary tumour.
    Chiarini V; Graziano E; Cremonini N; Frank G; Zampa GA
    Neurochirurgia (Stuttg); 1987 Mar; 30(2):61-3. PubMed ID: 3106846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of human serum thyrotrophin.
    Hall R; Amos J; Ormston BJ
    Br Med J; 1971 Mar; 1(5749):582-5. PubMed ID: 5548300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of synthetic TRH on human prolactin (HPr) secretion].
    Kato Y; Ogo S; Chihara K; Imura H
    Nihon Naibunpi Gakkai Zasshi; 1973 Sep; 49(9):1215-22. PubMed ID: 4201607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Practical value of radioimmunoassay of pituitary thyreotropic hormone].
    Chaussain JL; Job JC
    Ann Endocrinol (Paris); 1972; 33(6):557-70. PubMed ID: 4198751
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone.
    Patel YC; Burger HG
    J Clin Endocrinol Metab; 1973 Aug; 37(2):190-6. PubMed ID: 4352630
    [No Abstract]   [Full Text] [Related]  

  • 13. Case of hyperthyroidism due to a chromophobe adenoma.
    Baylis PH
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):145-50. PubMed ID: 1269160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioimmunoassay of plasma H. TSH, II. Results in normal subjects and in pathology].
    Jaquet P; Franchimont P; Rinaldi JP; Sainty JM; Codaccioni JL; Vague J
    Ann Endocrinol (Paris); 1971; 52(4):495-507. PubMed ID: 5171844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Further findings on the action of synthetic thyrotropin releasing hormone on the TSH serum level in various endocrine diseases].
    Wagner H; Böckel K; Grote G; Hrubesch M; Vosberg H; Junge-Hülsing G; Hauss WH
    Med Welt; 1972 Oct; 23(41):1419-21. PubMed ID: 4628828
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of serum thyrotropin (TSH) and stimulation with thyrotropin-releasing hormone (TRH) in thyroid diseases.
    Lauridsen UB; Deckert T; Friis T; Kirkegaard C; Hansen JM; Siersbaek-Nielsen K
    Acta Med Scand; 1974 Sep; 196(3):171-6. PubMed ID: 4214089
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothyroidism secondary to biologically inactive thyroid-stimulating hormone secretion by a pituitary chromophobe adenoma: recovery after removal of the tumor.
    Dickstein G; Barzilai D
    Arch Intern Med; 1982 Aug; 142(8):1544-5. PubMed ID: 7103637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of TRF in the study of pituitary reserve of TSH].
    Cantalamessa L; Reschini E; Giustina G; Miedico D; Valentini F; Beretta F
    Folia Endocrinol; 1973 Feb; 26(1):57-70. PubMed ID: 4633898
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromophobe pituitary adenoma with acromegaly and TSH-induced hyperthyroidism associated with parathyroid adenoma. Acromegaly and parathyroid adenoma.
    Lamberg BA; Ripatti J; Gordin A; Juustila H; Sivula A; af Björkesten G
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):157-72. PubMed ID: 4308288
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunoassay of thyroid-stimulating hormone and its clinical applications.
    Hall R
    Clin Endocrinol (Oxf); 1972 Jan; 1(1):115-25. PubMed ID: 4200175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.